ArticleInfection and drug resistance2026
Hospital-Based Surveillance and Resistance Index Analysis of Antimicrobial Resistance Trends: A Three-Year Study from a Tertiary Hospital in Iran (2021-2023).
Article in Infection and drug resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Evaluation of Virulence Profiles and Molecular Typing of ESBL-Producing UropathogenicInfection and drug resistance · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Antimicrobial resistance (AMR) poses an escalating global health crisis, yet institution-level temporal analyses that integrate both resistance trends and composite indices remain scarce. Methods: We performed a three-year retrospective analysis (2021-2023) of all culture-positive bacterial isolates from a tertiary referral hospital in Iran. Antimicrobial susceptibility testing (AST) followed CLSI M02/M07/M100 standards. Annual resistance rates (%R) were calculated for six priority pathogens, and linear regression was used to model temporal changes (slopes, p-values). A composite Resistance Index (RI) was derived to capture cumulative resistance pressure. Results: Among 38,514 specimens, 3109 (8.1%) yielded bacterial growth. Conclusion: This single-center study demonstrates shifting AMR epidemiology with
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.